Zusammenfassung
In etwa 60–90 % der Schmerzzustände bei Tumorpatienten sind durch Infiltration, Kompressionen mit konsekutiver Durchblutungsstörung, Ödem, Ulzeration oder Perforation direkt tumorbedingt. 10–25 % der Schmerzzustände sind therapiebedingt. Operation, Chemotherapie, Hormontherapie oder Radiatio können schmerzhafte Folgezustände wie z. B. Neuralgien, Phantomschmerz, Fibrose, Mukositis oder Ödem verursachen. Außerdem unterscheidet man zwischen tumorassoziierten Schmerzursachen wie z. B. Pneumonie, Pilzinfektion, Venenthrombose, Dekubitus (5–20 %) und tumorunabhängigen Schmerzursachen wie z. B. Migräne oder Arthrits (3–10 %). Neben somatischen Ursachen beeinflussen kulturelle, psychosoziale und spirituelle Faktoren das Schmerzerleben. Pathophysiologisch unterteilt man den Karzinomschmerz in den Nozizeptorschmerz und neuropathischen Schmerz bzw. gemischten Schmerz.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Cleary JF (2000) Cancer pain management. Cancer Control 7(2):120–131
Eisenberg E, Carr DB, Chalmers TC (1995) Neurolytic celiac plexus block for treatment of cancer pain: a metaanalysis. Anesth Analg 80(2):290–295
Felleiter P, Gustorff B, Lierz P, Hornykewycz S, Kress HG (2005) Use of the World Health Organisation guidelines on cancer pain relief before referral to a specialized pain service. Schmerz 19(4):265–271
Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118(3):289–305
Janig H, Pipam W, Lastin S, Sittl R, Bernatzky G, Likar R (2005) Pain experience and pain therapy of tumor patients in the view of general practitioners. Schmerz 19(2):97–108
Lema MJ (2001) Invasive analgesia techniques for advanced cancer pain. Surg Oncol Clin N Am 10(1):127–136
Maj S, Centkowski P (2004) A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland. Med Sci Monit 10(9):P193–P195
Mercadante S, Fulfaro F, Casuccio A (2002a) A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer 38(10):1358–1363
Mercadante S, Radbruch L, Caraceni A, Cherny N, Kaasa S, Nauck F, Ripamonti C, De Conno F (2002b) Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94(3):832–839
Munir MA, Enany N, Zhang JM (2007) Nonopioid analgesics. Med Clin North Am 91(1):97–111
Platzer M, Likar R, Stein C, Beubler E, Sittl R (2005) Topical application of morphine gel in inflammatory mucosal and cutaneous lesions. Schmerz 19(4):296–301
Sittl R, Nuijten M, Nautrup BP (2006) Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany. Clin Ther 28(8):1144–1154
Stute P, Soukup J, Menzel M, Sabatowski R, Grond S (2006) Analysis and treatment of different types of neuropathic cancer pain. J Pain Symtom Manage 26(6):1123–1131
Valeberg BT, Rustøen T, Bjordal K, Hanestad BR, Paul S, Miaskowski C (2008) Self-reported prevalence, etiology, and characteristics of pain in oncology outpatients. Eur J Pain 12(5):582–590
Vissers KC, Besse K, Wagemans M, Zuurmond W, Giezeman MJ, Lataster A, Mekhail N, Burton AW, van Kleef M, Huygen F (2011) 23. Pain in patients with cancer. Pain Pract Sep–Oct 11(5):453–75. https://doi.org/10.1111/j.1533-2500.2011.00473.x. Epub 2011 Jun 17
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this chapter
Cite this chapter
Likar, R., Köstenberger, M., Neuwersch-Sommeregger, S. (2023). Schmerztherapie bei Tumorpatienten. In: Bernatzky, G., Sittl, R., Likar, R. (eds) Schmerzbehandlung in der Palliativmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64329-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-64329-7_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-64328-0
Online ISBN: 978-3-662-64329-7
eBook Packages: Medicine (German Language)